These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33549134)

  • 21. Potential association of single nucleotide polymorphisms in pigmentation genes with the development of basal cell carcinoma.
    Kosiniak-Kamysz A; Pośpiech E; Wojas-Pelc A; Marcińska M; Branicki W
    J Dermatol; 2012 Aug; 39(8):693-8. PubMed ID: 22512251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin.
    Rizzato C; Canzian F; Rudnai P; Gurzau E; Stein A; Koppova K; Hemminki K; Kumar R; Campa D
    Carcinogenesis; 2011 Dec; 32(12):1849-54. PubMed ID: 21880580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. xWAS analysis in neuropsychiatric disorders by integrating multi-molecular phenotype quantitative trait loci and GWAS summary data.
    Luo L; Pang T; Zheng H; Liufu C; Chang S
    J Transl Med; 2024 Apr; 22(1):387. PubMed ID: 38664746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein-protein interaction and pathway analyses of top schizophrenia genes reveal schizophrenia susceptibility genes converge on common molecular networks and enrichment of nucleosome (chromatin) assembly genes in schizophrenia susceptibility loci.
    Luo X; Huang L; Jia P; Li M; Su B; Zhao Z; Gan L
    Schizophr Bull; 2014 Jan; 40(1):39-49. PubMed ID: 23671194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss-of-Function Variants in the Tumor-Suppressor Gene
    Olafsdottir T; Stacey SN; Sveinbjornsson G; Thorleifsson G; Norland K; Sigurgeirsson B; Thorisdottir K; Kristjansson AK; Tryggvadottir L; Sarin KY; Benediktsson R; Jonasson JG; Sigurdsson A; Jonasdottir A; Kristmundsdottir S; Jonsson H; Gylfason A; Oddsson A; Fridriksdottir R; Gudjonsson SA; Zink F; Lund SH; Rognvaldsson S; Melsted P; Steinthorsdottir V; Gudmundsson J; Mikaelsdottir E; Olason PI; Stefansdottir L; Eggertsson HP; Halldorsson BV; Thorsteinsdottir U; Agustsson TT; Olafsson K; Olafsson JH; Sulem P; Rafnar T; Gudbjartsson DF; Stefansson K
    Cancer Res; 2021 Apr; 81(8):1954-1964. PubMed ID: 33602785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the Molecular Genetics of Basal Cell Carcinoma.
    Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A genome-wide analysis of gene-caffeine consumption interaction on basal cell carcinoma.
    Li X; Cornelis MC; Liang L; Song F; De Vivo I; Giovannucci E; Tang JY; Han J
    Carcinogenesis; 2016 Dec; 37(12):1138-1143. PubMed ID: 27797824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploratory investigation of genetic associations with basal cell carcinoma risk: genome-wide association study in Jeju Island, Korea.
    Yun BM; Song JK; Lee JY
    Asian Pac J Cancer Prev; 2014; 15(17):7443-7. PubMed ID: 25227856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association study indicates combined effect of interleukin-10 and angiotensin-converting enzyme in basal cell carcinoma development.
    Koronellos N; Yapijakis C; Katoulis A; Avgoustidis D; Vylliotis A; Papakosta V; Diamantopoulou S; Zografos O; Vairaktari G; Vairaktaris E; Vassiliou S
    Arch Dermatol Res; 2021 Jul; 313(5):373-380. PubMed ID: 32772162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleiotropic Effects of Trait-Associated Genetic Variation on DNA Methylation: Utility for Refining GWAS Loci.
    Hannon E; Weedon M; Bray N; O'Donovan M; Mill J
    Am J Hum Genet; 2017 Jun; 100(6):954-959. PubMed ID: 28528868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network.
    Richard AC; Peters JE; Lee JC; Vahedi G; Schäffer AA; Siegel RM; Lyons PA; Smith KG
    Genome Med; 2016 Jul; 8(1):76. PubMed ID: 27435189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTCH1 gene haplotype association with basal cell carcinoma after transplantation.
    Begnini A; Tessari G; Turco A; Malerba G; Naldi L; Gotti E; Boschiero L; Forni A; Rugiu C; Piaserico S; Fortina AB; Brunello A; Cascone C; Girolomoni G; Gomez Lira M
    Br J Dermatol; 2010 Aug; 163(2):364-70. PubMed ID: 20346027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies.
    Zhao J; Cheng F; Jia P; Cox N; Denny JC; Zhao Z
    Genome Med; 2018 Jan; 10(1):7. PubMed ID: 29378629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.
    Welsh MM; Applebaum KM; Spencer SK; Perry AE; Karagas MR; Nelson HH
    Cancer Res; 2009 Aug; 69(15):6158-63. PubMed ID: 19622768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer.
    Jorgensen TJ; Ruczinski I; Yao Shugart Y; Wheless L; Berthier Schaad Y; Kessing B; Hoffman-Bolton J; Helzlsouer KJ; Kao WH; Francis L; Alani RM; Strickland PT; Smith MW; Alberg AJ
    Cancer Epidemiol; 2012 Oct; 36(5):e288-93. PubMed ID: 22677152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.
    Han J; Qureshi AA; Nan H; Zhang J; Song Y; Guo Q; Hunter DJ
    Cancer Res; 2011 Mar; 71(5):1533-9. PubMed ID: 21270109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing a network view of type 2 diabetes risk pathways through integration of genetic, genomic and functional data.
    Fernández-Tajes J; Gaulton KJ; van de Bunt M; Torres J; Thurner M; Mahajan A; Gloyn AL; Lage K; McCarthy MI
    Genome Med; 2019 Mar; 11(1):19. PubMed ID: 30914061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-Wide Expression Difference of MicroRNAs in Basal Cell Carcinoma.
    Wei HP; Zhan S; Zhu QA; Chen ZJ; Feng X; Chen JY; Zhang QL; Zhao J; Meng L
    J Immunol Res; 2021; 2021():7223500. PubMed ID: 34395634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of IL-2 and IL-10 gene polymorphisms and serum levels in patients with basal-cell carcinoma.
    Sobjanek M; Zabłotna M; Bień E; Gleń J; Sokołowska-Wojdyło M; Ruckemann-Dziurdzińska K; Nowicki R
    Biomark Med; 2016; 10(2):185-95. PubMed ID: 26609634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of summary data from GWAS and eQTL studies identified novel risk genes for coronary artery disease.
    Zhong Y; Chen L; Li J; Yao Y; Liu Q; Niu K; Ma Y; Xu Y
    Medicine (Baltimore); 2021 Mar; 100(11):e24769. PubMed ID: 33725943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.